References
- Chan TM, Lok AS, Cheng IK, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology. 1993;17:5–8
- Furusyo N, Hayashi J, Kakuda K, et al. Acute hepatitis C among Japanese hemodialysis patients: A prospective 9-year study. Am J Gastroenterol. 2001;96:1592–1600
- Keyvani H, Agah S, Kabir A, Alavian SM. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: A nationwide study. Ann Hepatol. 2013;12:213–219
- Avila RE, Carmo RA, Farah Kde P, et al. Hyaluronic acid in the evaluation of liver fibrosis in patients with hepatitis C on haemodialysis. Braz J Infect Dis. 2010;14:335–341
- Furusyo N, Hayashi J, Kanamoto-Tanaka Y, et al. Liver damage in hemodialysis patients with hepatitis C virus viremia: A prospective 10-year study. Dig Dis Sci. 2000;45:2221–2228
- Plevris JN, Haydon GH, Simpson KJ. Serum hyaluronan: A non-invasive test for diagnosing liver cirrhosis. Eur J Gastroenterol Hepatol. 2000;12:1121–1127
- Orăşan OH, Sava M, Iancu M, et al. Serum hyaluronic acid in chronic viral hepatitis B and C: A biomarker for assessing liver fibrosis in chronic hemodialysis patients. Int Urol Nephrol. 2015;47:1209–1217
- Grigorescu M, Romanian Society of Gastroenterology and Hepatology. HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C. J Gastrointestin Liver Dis. 2009;18:45–50
- Drugan C, Brichler S, Muntean M, et al. Genotype of hepatitis B virus in Romanian patients. App Med Inform. 2008;22:55–61